» Articles » PMID: 39272656

Advancing Prostate Cancer Diagnosis: A Deep Learning Approach for Enhanced Detection in MRI Images

Overview
Specialty Radiology
Date 2024 Sep 14
PMID 39272656
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer remains a leading cause of mortality among men globally, necessitating advancements in diagnostic methodologies to improve detection and treatment outcomes. Magnetic Resonance Imaging has emerged as a crucial technique for the detection of prostate cancer, with current research focusing on the integration of deep learning frameworks to refine this diagnostic process. This study employs a comprehensive approach using multiple deep learning models, including a three-dimensional (3D) Convolutional Neural Network, a Residual Network, and an Inception Network to enhance the accuracy and robustness of prostate cancer detection. By leveraging the complementary strengths of these models through an ensemble method and soft voting technique, the study aims to achieve superior diagnostic performance. The proposed methodology demonstrates state-of-the-art results, with the ensemble model achieving an overall accuracy of 91.3%, a sensitivity of 90.2%, a specificity of 92.1%, a precision of 89.8%, and an F1 score of 90.0% when applied to MRI images from the SPIE-AAPM-NCI PROSTATEx dataset. Evaluation of the models involved meticulous pre-processing, data augmentation, and the use of advanced deep-learning architectures to analyze the whole MRI slices and volumes. The findings highlight the potential of using an ensemble approach to significantly improve prostate cancer diagnostics, offering a robust and precise tool for clinical applications.

References
1.
Green H, Merriel S, Oram R, Ruth K, Tyrrell J, Jones S . Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank. Br J Cancer. 2022; 127(8):1534-1539. PMC: 9553867. DOI: 10.1038/s41416-022-01918-z. View

2.
Kryvenko O, Epstein J . Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System. Arch Pathol Lab Med. 2016; 140(10):1140-52. DOI: 10.5858/arpa.2015-0487-SA. View

3.
Meyer A, Chlebus G, Rak M, Schindele D, Schostak M, van Ginneken B . Anisotropic 3D Multi-Stream CNN for Accurate Prostate Segmentation from Multi-Planar MRI. Comput Methods Programs Biomed. 2020; 200:105821. DOI: 10.1016/j.cmpb.2020.105821. View

4.
Zhu L, Pan J, Mou W, Deng L, Zhu Y, Wang Y . Harnessing artificial intelligence for prostate cancer management. Cell Rep Med. 2024; 5(4):101506. PMC: 11031422. DOI: 10.1016/j.xcrm.2024.101506. View

5.
Turkbey B, Brown A, Sankineni S, Wood B, Pinto P, Choyke P . Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin. 2015; 66(4):326-36. PMC: 7511979. DOI: 10.3322/caac.21333. View